Central Nervous System Rhabdoid Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-07
Clinical Trial Update: GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) [Phase 1]
Phase 1 trial evaluating GPC3 CAR T cells with IL-15 and IL-21 for recurrent atypical teratoid rhabdoid tumor and CNS rhabdoid tumors; curre…